Invited talks: What´s new in nanotechnology?
| 09:00-09:40 | What‘s needed in nanomedicine? Twan Lammers, Department Nanomedicines and Theranostics, RWTH, Aachen University, Germany |
| 09:40-10:20 | to be determind to be determind |
| 10:20-11:00 | Hyperloaded polymeric micelles for chemo and immunotherapy Alexander Kabanov, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA |
Invited talks: Solid dosage forms
| 09:00-09:40 | Adoption of the MCS concept in the pharmaceutical industry Michael Leane, Bristol-Myers Squibb, New York City, USA/Anikó Szepes, F. Hoffmann-La Roche, Basel, Switzerland |
| 09:40-10:20 | Process design for innovative drug delivery systems Jukka Rantanen, Department of Pharmacy, University of Copenhagen, Denmark |
| 10:20-11:00 | The importance of understanding the physical and chemical properties of APIs in the digital design of drug products Kevin Roberts, Faculty of Engineering, University of Leeds, United Kingdom |
Short talks: Controlled drug delivery
| 09:00-09:20 | Design and control of a floating gastroretentive drug delivery system made by hot-melt tube extrusion Paul Bebernik, University of Bonn, Germany |
| 09:20-09:40 | A new calcium oral-controlled-release system based on zeolite for prevention of osteoporosis Ylenia Zambito, University of Pisa, Italy |
| 09:40-10:00 | Spray dried microparticulate drug delivery systems for long-term local osteoarthritis treatment Carlota Salgado, University of Geneva, Switzerland |
| 10:00-10:20 | Tuning the mechanical poreperties and release profile on an antimicrobial peptide from an injectable hydrogel using glycol chitosan James Flynn, University of Limerick, Ireland |
| 10:20-10:40 | Development of N-acetylcysteine-functionalized microcontainers for degredation of biofilm matrix Stine Egebro Birk, Technical University of Denmark, Lyngby, Denmark |
| 10:40-11:00 | SynBiosys® based long acting injectable miroparticle formulations for large proteins Tanja Henzler, Merck, Darmstadt, Germany |
Short talks: Pulmonary, nasal and buccal delivery
| 09:00-09:20 | High potency, brittle matrix tacrolimus powders for dry powder for inhalation by thin film freezing Sawittree Sahakijpijarn, University of Texas at Austin, USA [TBC] |
| 09:20-09:40 | Delivery of beclomethasone dipropionate nanosuspensions via electronic cigarette Luca Casula, University of Cagliari, Italy |
| 09:40-10:00 | P. aeruginosa biofilm infectred bronchial epithelium as test-system for anti-infective aerosol formulations Claus-Michael Lehr, Saarland University, Saarbrücken, Germany |
| 10:00-10:20 | Evaluation of a novel probiotic nasal spray in human volunteers Filip Kiekens, University of Antwerp, Belgium |
| 10:20-10:40 | Nanofibers with antibiotics and probiotics for the two-stage therapy of peridontal disease Spela Zupancic, University of Ljubljana, Slovenia |
| 10:40-11:00 | Mucoadhesive films to elicit nanoparticle buccal permeation Javier Morales, University de Chile, Santiago, Chile |
APGI award session and plenary lecture
| 11:30-13:00 | Advances in nanotechnology Patrick Courvreur, Faculty of Pharmaceutical Sciences, Paris Sud University, France |
Invited talks: Advanced therapeutic products: an industrial perspective
| 15:00-15:40 | Formulation approaches for cell and gene therapies Chris Van der Walle, MedImmune, Cambridge, United Kingdom |
| 15:40-16:20 | Lentiviral vector-based medicines from concept to market James Miskin, Oxford Biomedica, United Kingdom |
| 16:20-17:00 | Biodrugs and advanced therapy medicinal products: a revolution in medicine Maria Luisa Nolli, NCNbio, Milan, Italy |
Invited talks: 3D-printing
| 15:00-15:40 | 3D-printing of medicines and implants: making the formulations work Clive Roberts, School of Pharmacy, University of Nottingham, United Kingdom |
| 15:40-16:20 | 3D-printing of medicines at the point of care: fantasy or the future? Matthew Peak, Alder Hey Children’s Hospital, Liverpool, United Kingdom |
| 16:20-17:00 | 3D printing in an industrial GMP setting Jaedeok Yoo, Aprecia Pharmaceuticals, Blue Ash, OH, USA |
Short talks: Preformulation and bioavailability
| 15:00-15:20 | In situ drug amorphization using laser irradiation Nele-Johanna Hempel, University of Copenhagen, Denmark |
| 15:20-15:40 | In-depth exploration of the intensified vibratory mill: a modern design of experiments approach Elene De Cleyn, KU Leuven, Belgium |
| 15:40-16:00 | Evaluation of different preprocessing methods of x-ray micro computed tomography images Sebastian Bollmann, Univeristy of Düsseldorf, Germany |
| 16:00-16:20 | Preliminary experimental and numerical studies of the cohesion of pharmaceutical particles of wet granules Maroua Rouabah, Claude Bernard University Lyon 1, France |
| 16:20-16:40 | Amorphous drug-polyelectrolyte nanoparticle complex as a solubility enhancement strategy of poorly-soluble drugs Kunn Hadinoto, Nanyang Techonological University, Singapore |
| 16:40-17:00 | Insight into amorphous solid dispersion dissolution behaviour: laser-diffraction and Raman spectroscopy holding hands Maria Paisana, Hovione FarmaCiencia, Lisbon, Portugal |
Short talks: Tablets and coated tablets
| 15:00-15:20 | Profiling the influence of process parameters on the interfacial properties of bilayer tablets Jan Hendrik Finke, Technical University of Braunschweig, Germany |
| 15:20-15:40 | Evaluation of the performance of an external lubrication system implemented in a compaction simulator Cedrine de Backere, Ghent University, Ghent, Belgium |
| 15:40-16:00 | Influence of the unloading conditions on capping and lamination during tableting: numerical and experimental study Vincent Mazel, University of Bordeaux, France |
| 16:00-16:20 | to be determind to be determind |
| 16:20-16:40 | High solids film coating systems: continuous vs. batch processing Christian Mühlenfeld, Ashland Industries Deutschland GmbH, Düsseldorf, Germany |
| 16:40-17:00 | to be determind to be determind |